An anti‐platelet agent, OPC‐29030, inhibits translocation of 12‐lipoxygenase and 12‐hydroxyeicosatetraenoic acid production in human platelets
- 1 December 1999
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 128 (8), 1699-1704
- https://doi.org/10.1038/sj.bjp.0702976
Abstract
1. In human platelets, arachidonic acid is mainly metabolized by the two enzyme systems; cyclo-oxygenase and 12-lipoxygenase. Cyclo-oxygenase produces prostaglandin H(2) which is further converted to thromboxane B(2). 12-Lipoxygenase synthesizes 12(S)-hydroperoxyeicosatetraenoic acid which is reduced to 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE). 2. An anti-platelet compound, OPC-29030, dose-dependently inhibited 12(S)-HETE production with an IC(50) of 0.06+/-0.01 microM, but not synthesis of thromboxane B(2) in human platelets. Although the compound suppressed 12(S)-HETE production in human platelets, cytosolic 12-lipoxygenase activity was not inhibited up to 10 microM. Essentially identical data were obtained with a 12-lipoxygenase of human erythroleukaemia cells which had megakaryocyte/platelet-like properties. 3. OPC-29030 also suppressed production of 5(S)-HETE, a 5-lipoxygenase product, in rat basophilic leukaemia cells without inhibiting enzyme activity. It has been shown that 5-lipoxygenase binds to membrane 5-lipoxygenase-activating protein (FLAP) to produce 5(S)-HETE, and thus FLAP inhibitor suppresses cellular 5(S)-HETE production. 4. A FLAP inhibitor, L-655,238, suppressed platelet 12(S)-HETE production, but had no effect on the 12-lipoxygenase activity. 5. Western blot analysis showed that platelet 12-lipoxygenase translocated from cytosol to membranes upon thrombin stimulation, and OPC-29030 suppressed this process in a dose-dependent manner. 6. These results suggest that the 12-lipoxygenase of human platelets binds to FLAP or a similar protein, and OPC-29030 suppresses 12(S)-HETE production by inhibiting a certain step of the 12-lipoxygenase translocation.Keywords
This publication has 30 references indexed in Scilit:
- 12(S)-HETE plays a role as a mediator of expression of platelet CD62 (P-selectin)Platelets, 1998
- Translocation and Leukotriene Synthetic Capacity of Nuclear 5-Lipoxygenase in Rat Basophilic Leukemia Cells and Alveolar MacrophagesPublished by Elsevier ,1995
- Synthesis of 2(1H)-Quinolinone Derivatives and Their Inhibitory Activity on the Release of 12(S)-Hydroxyeicosatetraenoic Acid (12-HETE) from Platelets.CHEMICAL & PHARMACEUTICAL BULLETIN, 1995
- Studies on the role of platelet eicosanoid metabolism and integrin αIIbβ3 in tumor‐cell‐induced platelet aggregationInternational Journal of Cancer, 1993
- Induction of cyclooxygenase and suppression of 12-lipoxygenase in human erythroleukemia cells upon phorbol ester-induced differentiationBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993
- 12 -Hydroxyeicosatetraenoic acid plays a central role in the regulation of platelet activationBiochemical and Biophysical Research Communications, 1991
- Feedback regulation of platelet function by 12 S-hydroxyeicosatetraenoic acid: Inhibition of arachidonic acid liberation from phospholipidsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Extraction of Various Arachidonic Acid Metabolites from Minimal Amounts of Biological Fluid with a New Generation of Miniaturized Solid Phase Extraction CartridgesJournal of Liquid Chromatography, 1990
- Measurement of arachidonic acid liberation in thrombin-stimulated human platelets. Use of agents that inhibit both the cyclooxygenase and lipoxygenase enzymesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1985
- Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and InflammationScience, 1983